Daybue (trofinetide oral solution - Acadia) — Cigna
Rett syndrome
Initial criteria
- Approval is not recommended for any use, including Rett syndrome. Daybue is considered not medically necessary for all indications.
Reauthorization criteria
- Reauthorization is not applicable since initial approval is not recommended.